Zepbound

NDC 0002-2002 · Eli Lilly and Company

Generic nametirzepatide

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)TIRZEPATIDE

Strength15 mg/.5mL

Pharmacologic classG-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]

Marketing categoryNDA

Packages

0002-2002-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-2002-01) / .5 mL in 1 VIAL, SINGLE-DOSE

0002-2002-04 — 4 VIAL, SINGLE-DOSE in 1 CARTON (0002-2002-04) / .5 mL in 1 VIAL, SINGLE-DOSE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0002-1214 — tirzepatide, 0002-1243 — tirzepatide, 0002-1340 — tirzepatide, 0002-1423 — tirzepatide, 0002-1457 — tirzepatide, 0002-1460 — tirzepatide, 0002-1471 — tirzepatide, 0002-1484 — tirzepatide, 0002-1495 — tirzepatide, 0002-1506 — tirzepatide, 0002-2214 — tirzepatide, 0002-2340 — tirzepatide, 0002-2423 — tirzepatide, 0002-2457 — tirzepatide, 0002-2460 — tirzepatide, 0002-2471 — tirzepatide, 0002-2484 — tirzepatide, 0002-2495 — tirzepatide, 0002-2506 — tirzepatide, 0002-3002 — tirzepatide, +33 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.